ID   PLCE_HUMAN              Reviewed;         364 AA.
AC   Q9NUQ2; Q8IZ47; Q9BQG4;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2003, sequence version 3.
DT   10-MAY-2017, entry version 133.
DE   RecName: Full=1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon;
DE            EC=2.3.1.51;
DE   AltName: Full=1-acylglycerol-3-phosphate O-acyltransferase 5;
DE            Short=1-AGP acyltransferase 5;
DE            Short=1-AGPAT 5;
DE   AltName: Full=Lysophosphatidic acid acyltransferase epsilon;
DE            Short=LPAAT-epsilon;
GN   Name=AGPAT5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Leung D.W.;
RT   "Cloning and expression of LPAAT-epsilon.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 9-364.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=16620771; DOI=10.1016/j.abb.2006.03.014;
RA   Agarwal A.K., Barnes R.I., Garg A.;
RT   "Functional characterization of human 1-acylglycerol-3-phosphate
RT   acyltransferase isoform 8: cloning, tissue distribution, gene
RT   structure, and enzymatic activity.";
RL   Arch. Biochem. Biophys. 449:64-76(2006).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21173190; DOI=10.1194/jlr.M007575;
RA   Prasad S.S., Garg A., Agarwal A.K.;
RT   "Enzymatic activities of the human AGPAT isoform 3 and isoform 5:
RT   localization of AGPAT5 to mitochondria.";
RL   J. Lipid Res. 52:451-462(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Converts lysophosphatidic acid (LPA) into phosphatidic
CC       acid by incorporating an acyl moiety at the sn-2 position of the
CC       glycerol backbone. Acts on LPA containing saturated or unsaturated
CC       fatty acids C15:0-C20:4 at the sn-1 position using C18:1-CoA as
CC       the acyl donor. Also acts on lysophosphatidylethanolamine using
CC       oleoyl-CoA, but not arachidonoyl-CoA, and lysophosphatidylinositol
CC       using arachidonoyl-CoA, but not oleoyl-CoA. Activity toward
CC       lysophosphatidylglycerol not detectable.
CC       {ECO:0000269|PubMed:21173190}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycerol 3-phosphate =
CC       CoA + 1,2-diacyl-sn-glycerol 3-phosphate.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=5.52 uM for LPA sn-1 C18:1;
CC         KM=16.30 uM for C18:1-CoA;
CC         Vmax=2.42 nmol/min/mg enzyme toward LPA sn-1 C18:1;
CC         Vmax=1.22 nmol/min/mg enzyme toward C18:1-CoA;
CC   -!- PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis;
CC       CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3.
CC   -!- INTERACTION:
CC       Q9UMX0:UBQLN1; NbExp=5; IntAct=EBI-6916385, EBI-741480;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:21173190}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:21173190}. Nucleus envelope
CC       {ECO:0000269|PubMed:21173190}. Mitochondrion
CC       {ECO:0000269|PubMed:21173190}.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:16620771, ECO:0000269|PubMed:21173190}.
CC   -!- DOMAIN: The HXXXXD motif is essential for acyltransferase activity
CC       and may constitute the binding site for the phosphate moiety of
CC       the glycerol-3-phosphate. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the 1-acyl-sn-glycerol-3-phosphate
CC       acyltransferase family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-12 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92069.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF375789; AAK54809.1; -; mRNA.
DR   EMBL; AL136587; CAB66522.1; -; mRNA.
DR   EMBL; BC023550; AAH23550.1; -; mRNA.
DR   EMBL; BC080537; AAH80537.1; -; mRNA.
DR   EMBL; AK002072; BAA92069.1; ALT_INIT; mRNA.
DR   CCDS; CCDS34796.1; -.
DR   RefSeq; NP_060831.2; NM_018361.3.
DR   UniGene; Hs.624002; -.
DR   ProteinModelPortal; Q9NUQ2; -.
DR   SMR; Q9NUQ2; -.
DR   BioGrid; 120607; 9.
DR   IntAct; Q9NUQ2; 3.
DR   MINT; MINT-4725223; -.
DR   STRING; 9606.ENSP00000285518; -.
DR   SwissLipids; SLP:000000822; -.
DR   iPTMnet; Q9NUQ2; -.
DR   PhosphoSitePlus; Q9NUQ2; -.
DR   SwissPalm; Q9NUQ2; -.
DR   BioMuta; AGPAT5; -.
DR   DMDM; 30923427; -.
DR   EPD; Q9NUQ2; -.
DR   MaxQB; Q9NUQ2; -.
DR   PaxDb; Q9NUQ2; -.
DR   PeptideAtlas; Q9NUQ2; -.
DR   PRIDE; Q9NUQ2; -.
DR   DNASU; 55326; -.
DR   Ensembl; ENST00000285518; ENSP00000285518; ENSG00000155189.
DR   GeneID; 55326; -.
DR   KEGG; hsa:55326; -.
DR   UCSC; uc003wqo.4; human.
DR   CTD; 55326; -.
DR   DisGeNET; 55326; -.
DR   GeneCards; AGPAT5; -.
DR   HGNC; HGNC:20886; AGPAT5.
DR   HPA; HPA010644; -.
DR   HPA; HPA010950; -.
DR   MIM; 614796; gene.
DR   neXtProt; NX_Q9NUQ2; -.
DR   OpenTargets; ENSG00000155189; -.
DR   PharmGKB; PA134952751; -.
DR   eggNOG; KOG1505; Eukaryota.
DR   eggNOG; COG0204; LUCA.
DR   GeneTree; ENSGT00530000062943; -.
DR   HOGENOM; HOG000007801; -.
DR   HOVERGEN; HBG039632; -.
DR   InParanoid; Q9NUQ2; -.
DR   KO; K19007; -.
DR   OMA; WFPATIM; -.
DR   OrthoDB; EOG091G0C4Z; -.
DR   PhylomeDB; Q9NUQ2; -.
DR   TreeFam; TF314346; -.
DR   BioCyc; MetaCyc:HS08034-MONOMER; -.
DR   BRENDA; 2.3.1.51; 2681.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   Reactome; R-HSA-75109; Triglyceride Biosynthesis.
DR   UniPathway; UPA00557; UER00613.
DR   ChiTaRS; AGPAT5; human.
DR   GeneWiki; AGPAT5; -.
DR   GenomeRNAi; 55326; -.
DR   PRO; PR:Q9NUQ2; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000155189; -.
DR   CleanEx; HS_AGPAT5; -.
DR   ExpressionAtlas; Q9NUQ2; baseline and differential.
DR   Genevisible; Q9NUQ2; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005741; C:mitochondrial outer membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:LIFEdb.
DR   GO; GO:0005635; C:nuclear envelope; IEA:UniProtKB-SubCell.
DR   GO; GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome.
DR   InterPro; IPR032098; Acyltransf_C.
DR   InterPro; IPR002123; Plipid/glycerol_acylTrfase.
DR   Pfam; PF16076; Acyltransf_C; 1.
DR   Pfam; PF01553; Acyltransferase; 1.
DR   SMART; SM00563; PlsC; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Complete proteome; Endoplasmic reticulum;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Mitochondrion;
KW   Nucleus; Phospholipid biosynthesis; Phospholipid metabolism;
KW   Polymorphism; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    364       1-acyl-sn-glycerol-3-phosphate
FT                                acyltransferase epsilon.
FT                                /FTId=PRO_0000208200.
FT   TRANSMEM     15     35       Helical. {ECO:0000255}.
FT   TRANSMEM     61     81       Helical. {ECO:0000255}.
FT   TRANSMEM    344    364       Helical. {ECO:0000255}.
FT   MOTIF        93     98       HXXXXD motif.
FT   VARIANT      77     77       Y -> C (in dbSNP:rs17077958).
FT                                /FTId=VAR_022696.
FT   CONFLICT    156    156       L -> V (in Ref. 2; BAA92069).
FT                                {ECO:0000305}.
SQ   SEQUENCE   364 AA;  42072 MW;  90A0F87FC7C78081 CRC64;
     MLLSLVLHTY SMRYLLPSVV LLGTAPTYVL AWGVWRLLSA FLPARFYQAL DDRLYCVYQS
     MVLFFFENYT GVQILLYGDL PKNKENIIYL ANHQSTVDWI VADILAIRQN ALGHVRYVLK
     EGLKWLPLYG CYFAQHGGIY VKRSAKFNEK EMRNKLQSYV DAGTPMYLVI FPEGTRYNPE
     QTKVLSASQA FAAQRGLAVL KHVLTPRIKA THVAFDCMKN YLDAIYDVTV VYEGKDDGGQ
     RRESPTMTEF LCKECPKIHI HIDRIDKKDV PEEQEHMRRW LHERFEIKDK MLIEFYESPD
     PERRKRFPGK SVNSKLSIKK TLPSMLILSG LTAGMLMTDA GRKLYVNTWI YGTLLGCLWV
     TIKA
//
